Sagent Pharmaceuticals Inc., a Schaumberg, Ill.-based developer of injectable drugs, has raised $53 million in Series A funding led by Vivo Ventures. The company was founded in 2006, and says that it has more than 200 products in development. www.sagentpharma.com
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.